Pronađeno: 11-20 / 32 radova

Autori: Andric Zoran G

>> Prikaži sve rezultate

Naslov Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial (Article)
Autori Peters Solange  ...  Andric Zoran G  ...  (broj koautora 26) 
Info NATURE MEDICINE, (2022), vol. 28 br. 9, str. 1831-+
Projekat F. Hoffmann-La Roche, Ltd.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia (Article)
Autori Perovic-Blagojevic Iva M  Vekic Jelena Z  Macut Djuro P  Ignjatovic Svetlana D  Miljkovic-Trailovic Milica M  Zeljkovic Aleksandra R  Spasojevic-Kalimanovska Vesna V  Bozic-Antic Ivana B  Bjekic-Macut Jelica D  Kastratovic-Kotlica Biljana A  Andric Zoran G  Ilic Dusan S  Kotur-Stevuljevic Jelena M 
Info BRITISH JOURNAL OF NUTRITION, (2022), vol. 128 br. 4, str. 604-612
Projekat Serbian Ministry of Science and Education [200110, 451-03-9/2021-14/200161]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies (Article)
Autori Weiss Jared  Goldschmidt Jerome  Andric Zoran G  Dragnev Konstantin H  Gwaltney Chad  Skaltsa Konstantina  Pritchett Yili  Antal Joyce M  Morris Shannon R  Daniel Davey 
Info CLINICAL LUNG CANCER, (2021), vol. 22 br. 5, str. 449-460
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC (Article)
Autori Jassem Jacek  ...  Andric Zoran G  ...  (broj koautora 19) 
Info JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 11, str. 1872-1882
Projekat Roche HoldingGenentech; F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Polycystic Ovary Syndrome: A Contemporary Clinical Approach (Review)
Autori Bjekic-Macut Jelica D  Vukasin Tamara  Velija-Asimi Zelija  Burekovic Azra  Zdravkovic Marija D  Andric Zoran G  Brankovic Marija S  Crevar-Marinovic Slobodanka  Madic Tatjana  Stanojlovic Olivera P  Milutinovic Danijela V  Livadas Sarantis  Mastorakos George 
Info CURRENT PHARMACEUTICAL DESIGN, (2021), vol. 27 br. 36, str. 3812-3820
Projekat Ministry of Education, Science and Technological Development, Serbia [451-03-68/2020-14/200007]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article)
Autori Syrigos Konstantinos  Abert Istvan  Andric Zoran G  Bondarenko Igor N  Dvorkin Mikhail  Galic Kristina  Galiulin Rinat  Kuchava Vladimer  Sriuranpong Virote  Trukhin Dmytro  Zhavrid Edvard  Fu Dongyue  Kassalow Laurent M  Jones Stephanie  Bashir Zahid 
Info BIODRUGS, (2021), vol. 35 br. 4, str. 417-428
Projekat Centus Biotherapeutics
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA) (Article)
Autori Trukhin Dmytro  ...  Andric Zoran G  ...  (broj koautora 19) 
Info BIODRUGS, (2021), vol. 35 br. 4, str. 429-444
Projekat mAbxience Research SL
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study (Article)
Autori Hart Lowell L  Ferrarotto Renata  Andric Zoran G  Beck Thaddeus J  Subramanian Janakiraman  Radosavljevic Davorin Z  Zaric Bojan  Hanna Wahid T  Aljumaily Raid  Owonikoko Taofeek K  Verhoeven Didier  Xiao Jie  Morris Shannon R  Antal Joyce M  Hussein Maen A 
Info ADVANCES IN THERAPY, (2021), vol. 38 br. 1, str. 350-365
Projekat G1 Therapeutics, Inc. (Research Triangle Park, NC)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Assessment of age-related influences on the quality of life of breast cancer patients before and after surgical treatment (Article)
Autori Kostic Sanja V  Murtezani Zafir  Andric Zoran G  Ivanovic Nebojsa S  Kozomara Zoran K  Kostic Marko I  Milicic Vesna M  Kocic Sanja S 
Info VOJNOSANITETSKI PREGLED, (2020), vol. 77 br. 9, str. 908-916
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC (Article)
Autori Herbst Roy S  ...  Andric Zoran G  ...  (broj koautora 22) 
Info NEW ENGLAND JOURNAL OF MEDICINE, (2020), vol. 383 br. 14, str. 1328-1339
Projekat Roche HoldingGenentech; IMpower110 ClinicalTrials.gov number [NCT02409342]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX